Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

11,149 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
A Retrospective Comparison of the Clinical Efficacy of Gefitinib, Erlotinib, and Afatinib in Japanese Patients With Non-Small Cell Lung Cancer.
Fujiwara A, Yoshida M, Fujimoto H, Nakahara H, Ito K, Nishihama K, Yasuma T, Hataji O, Taguchi O, D'Alessandro-Gabazza CN, Gabazza EC, Kobayashi T. Fujiwara A, et al. Among authors: yoshida m. Oncol Res. 2018 Aug 23;26(7):1031-1036. doi: 10.3727/096504018X15151523767752. Epub 2018 Jan 10. Oncol Res. 2018. PMID: 29321093 Free PMC article.
Community-acquired pneumonia and nursing home-acquired pneumonia in the very elderly patients.
Maruyama T, Gabazza EC, Morser J, Takagi T, D'Alessandro-Gabazza C, Hirohata S, Nakayama S, Ramirez AY, Fujiwara A, Naito M, Nishikubo K, Yuda H, Yoshida M, Takei Y, Taguchi O. Maruyama T, et al. Among authors: yoshida m. Respir Med. 2010 Apr;104(4):584-92. doi: 10.1016/j.rmed.2009.12.008. Epub 2010 Jan 8. Respir Med. 2010. PMID: 20060700 Free article.
Role of thrombin-activatable fibrinolysis inhibitor in allergic bronchial asthma.
Fujiwara A, Taguchi O, Takagi T, D'Alessandro-Gabazza CN, Boveda-Ruiz D, Toda M, Yasukawa A, Matsushima Y, Miyake Y, Kobayashi H, Kobayashi T, Gil-Bernabe P, Naito M, Yoshida M, Morser J, Takei Y, Gabazza EC. Fujiwara A, et al. Among authors: yoshida m. Lung. 2012 Apr;190(2):189-98. doi: 10.1007/s00408-011-9337-9. Epub 2011 Oct 25. Lung. 2012. PMID: 22037793
A new strategy for healthcare-associated pneumonia: a 2-year prospective multicenter cohort study using risk factors for multidrug-resistant pathogens to select initial empiric therapy.
Maruyama T, Fujisawa T, Okuno M, Toyoshima H, Tsutsui K, Maeda H, Yuda H, Yoshida M, Kobayashi H, Taguchi O, Gabazza EC, Takei Y, Miyashita N, Ihara T, Brito V, Niederman MS. Maruyama T, et al. Among authors: yoshida m. Clin Infect Dis. 2013 Nov;57(10):1373-83. doi: 10.1093/cid/cit571. Epub 2013 Sep 2. Clin Infect Dis. 2013. PMID: 23999080
[First case of lung abscess due to Yersinia pseudotuberculosis in Japan].
Takahashi Y, Sasabe J, Maeda H, Fujiwara A, Yuda H, Yoshida M, Taguchi O. Takahashi Y, et al. Among authors: yoshida m. Kansenshogaku Zasshi. 2014 Jul;88(4):463-8. doi: 10.11150/kansenshogakuzasshi.88.463. Kansenshogaku Zasshi. 2014. PMID: 25199381 Japanese.
Sequential Therapy with Crizotinib and Alectinib in ALK-Rearranged Non-Small Cell Lung Cancer-A Multicenter Retrospective Study.
Ito K, Hataji O, Kobayashi H, Fujiwara A, Yoshida M, D'Alessandro-Gabazza CN, Itani H, Tanigawa M, Ikeda T, Fujiwara K, Fujimoto H, Kobayashi T, Gabazza EC, Taguchi O, Yamamoto N. Ito K, et al. Among authors: yoshida m. J Thorac Oncol. 2017 Feb;12(2):390-396. doi: 10.1016/j.jtho.2016.07.022. Epub 2016 Aug 4. J Thorac Oncol. 2017. PMID: 27498387 Free article.
Efficacy and Safety of Amrubicin in Small Cell Carcinoma Previously Treated with Immune Checkpoint Inhibitors and Chemotherapy.
Nishimura T, Fujimoto H, Fujiwara T, Ito K, Fujiwara A, Yuda H, Itani H, Naito M, Kodama S, Yagi A, D'Alessandro VF, Yasuma T, Furuhashi K, Saiki H, Okano T, Tomaru A, Tanigawa M, D'Alessandro-Gabazza CN, Gabazza EC, Yoshida M, Hataji O, Ibata H, Kobayashi T. Nishimura T, et al. Among authors: yoshida m. Cancers (Basel). 2022 Aug 16;14(16):3953. doi: 10.3390/cancers14163953. Cancers (Basel). 2022. PMID: 36010946 Free PMC article.
Impact of immune-related adverse events on survival outcomes in extensive-stage small cell lung cancer patients treated with immune checkpoint inhibitors.
Nishimura T, Fujimoto H, Fujiwara T, Ito K, Fujiwara A, Yuda H, Itani H, Naito M, Kodama S, Furuhashi K, Yagi A, Saiki H, Yasuma T, Okano T, Tomaru A, Tanigawa M, Yoshida M, Hataji O, Ibata H, D'Alessandro-Gabazza CN, Gabazza EC, Kobayashi T. Nishimura T, et al. Among authors: yoshida m. Cancer Med. 2024 Apr;13(8):e7188. doi: 10.1002/cam4.7188. Cancer Med. 2024. PMID: 38629295 Free PMC article.
A Therapeutic Strategy for All Pneumonia Patients: A 3-Year Prospective Multicenter Cohort Study Using Risk Factors for Multidrug-resistant Pathogens to Select Initial Empiric Therapy.
Maruyama T, Fujisawa T, Ishida T, Ito A, Oyamada Y, Fujimoto K, Yoshida M, Maeda H, Miyashita N, Nagai H, Imamura Y, Shime N, Suzuki S, Amishima M, Higa F, Kobayashi H, Suga S, Tsutsui K, Kohno S, Brito V, Niederman MS. Maruyama T, et al. Among authors: yoshida m. Clin Infect Dis. 2019 Mar 19;68(7):1080-1088. doi: 10.1093/cid/ciy631. Clin Infect Dis. 2019. PMID: 30084884
11,149 results
You have reached the last available page of results. Please see the User Guide for more information.